{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-099755","form_type":"8-K","ticker":"PHGE","cik":"0001739174","company_name":"BiomX Inc.","filed_at":"2025-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.287503+00:00","generated_at":"2026-05-17T03:24:47.361564+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"BiomX shareholders approve reverse stock split authorization and elect Class II directors","bullets":["Elected Susan Blum, Dr. Jesse Goodman, and Gregory Merril as Class II directors until 2028.","Approved board authority to reverse split common stock at a ratio between 1-for-5 and 1-for-20 (13.6M votes for, 383.7K against).","Ratified Kesselman & Kesselman (PwC member) as independent auditor for fiscal 2025 with 14.05M votes for.","Adjournment proposal not called due to sufficient votes on other proposals.","All three proposals passed; broker non-votes were zero on director elections."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-099755","json":"https://secwatch.observer/filing/0001213900-25-099755.json","markdown":"https://secwatch.observer/filing/0001213900-25-099755.md","text":"https://secwatch.observer/filing/0001213900-25-099755.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000121390025099755/0001213900-25-099755-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000121390025099755/ea0261608-8k_biomx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:24:47.361564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001108524-26-000131","ticker":"CRM","company_name":"Salesforce, Inc.","filed_at":"2026-06-01T20:43:09+00:00","headline":"Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected","event_type":"other_material","sec_items":["5.07","5.02","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001108524-26-000131","json":"https://secwatch.observer/filing/0001108524-26-000131.json","markdown":"https://secwatch.observer/filing/0001108524-26-000131.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1108524/000110852426000131/0001108524-26-000131-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1108524/000110852426000131/crm-20260528.htm"},"side_by_side_evidence":null},{"accession":"0000790816-26-000019","ticker":null,"company_name":"BRANDYWINE OPERATING PARTNERSHIP, L.P.","filed_at":"2026-06-01T20:30:42+00:00","headline":"Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP","event_type":"other_material","sec_items":["1.01","2.03","5.02","5.07","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000790816-26-000019","json":"https://secwatch.observer/filing/0000790816-26-000019.json","markdown":"https://secwatch.observer/filing/0000790816-26-000019.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1060386/000079081626000019/0000790816-26-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/790816/000079081626000019/bdn-20260528.htm"},"side_by_side_evidence":null},{"accession":"0000908937-26-000015","ticker":"SIRI","company_name":"SIRIUS XM HOLDINGS INC.","filed_at":"2026-06-01T20:28:55+00:00","headline":"Sirius XM shareholders approve 7.2M share increase in 2024 equity plan, elect directors","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000908937-26-000015","json":"https://secwatch.observer/filing/0000908937-26-000015.json","markdown":"https://secwatch.observer/filing/0000908937-26-000015.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/908937/000090893726000015/0000908937-26-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908937/000090893726000015/siri-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001628280-26-039518","ticker":"ESPR","company_name":"Esperion Therapeutics, Inc.","filed_at":"2026-06-01T20:22:15+00:00","headline":"Esperion shareholders approve 7M-share increase to 2022 equity incentive plan","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039518","json":"https://secwatch.observer/filing/0001628280-26-039518.json","markdown":"https://secwatch.observer/filing/0001628280-26-039518.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026039518/0001628280-26-039518-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026039518/espr-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-063110","ticker":"RDAC","company_name":"Rising Dragon Acquisition Corp.","filed_at":"2026-06-01T10:08:35+00:00","headline":"Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed","event_type":"other_material","sec_items":["1.01","5.03","5.07","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063110","json":"https://secwatch.observer/filing/0001213900-26-063110.json","markdown":"https://secwatch.observer/filing/0001213900-26-063110.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/0001213900-26-063110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/ea0292895-8k_rising.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-248680","ticker":"TNYA","company_name":"Tenaya Therapeutics, Inc.","filed_at":"2026-05-29T21:04:54+00:00","headline":"Tenaya shareholders approve amended equity plan adding 6.5M shares, elect directors","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-248680","json":"https://secwatch.observer/filing/0001193125-26-248680.json","markdown":"https://secwatch.observer/filing/0001193125-26-248680.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526248680/0001193125-26-248680-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526248680/tnya-20260527.htm"},"side_by_side_evidence":null},{"accession":"0001636282-26-000056","ticker":"SYRE","company_name":"Spyre Therapeutics, Inc.","filed_at":"2026-05-29T20:45:58+00:00","headline":"Spyre Therapeutics stockholders approve amended ESPP; director Peter Harwin resigns","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001636282-26-000056","json":"https://secwatch.observer/filing/0001636282-26-000056.json","markdown":"https://secwatch.observer/filing/0001636282-26-000056.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636282/000163628226000056/0001636282-26-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636282/000163628226000056/syre-20260527.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-248445","ticker":"EVC","company_name":"ENTRAVISION COMMUNICATIONS CORP","filed_at":"2026-05-29T20:30:20+00:00","headline":"Entravision stockholders approve 6M share increase in equity plan at annual meeting","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-248445","json":"https://secwatch.observer/filing/0001193125-26-248445.json","markdown":"https://secwatch.observer/filing/0001193125-26-248445.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1109116/000119312526248445/0001193125-26-248445-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1109116/000119312526248445/evc-20260528.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}